NCT06445153

Brief Summary

The project aims to improve patient safety, reduce barriers to the implementation of current guideline recommendations, reduce workload in clinics, increase efficiency in work processes and close gaps in care. Subprojects regarding delirium are implementes as well.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
845

participants targeted

Target at P75+ for not_applicable

Timeline
15mo left

Started Jun 2024

Typical duration for not_applicable

Geographic Reach
1 country

4 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress61%
Jun 2024Jul 2027

First Submitted

Initial submission to the registry

May 23, 2024

Completed
11 days until next milestone

Study Start

First participant enrolled

June 3, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 6, 2024

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2026

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2027

Expected
Last Updated

May 4, 2026

Status Verified

April 1, 2026

Enrollment Period

1.6 years

First QC Date

May 23, 2024

Last Update Submit

April 28, 2026

Conditions

Keywords

Clinical decision support system, Delirium risk factors, recommendations, surgery

Outcome Measures

Primary Outcomes (2)

  • Guideline adherence

    Guideline adherence: proportion of guideline recommendations fulfilled per patient in the first five postoperative days. The guideline adherence rate up to postoperative day 5 (or earlier if the patient has already been discharged) is calculated as a simple division: Number of recommendations fulfilled by number of all recommendations (N=6). A guideline adherence rate of at least 4 out of 6 points (67%) per patient is considered clinically sufficient.

    Up to five days

  • Postperative delirium- free days

    Number of postoperative delirium- free days within 5 days postoperatively per patient.

    Up to five days

Secondary Outcomes (50)

  • Causes of delirium

    Up to seven days

  • Changes of Electroencephalography

    Participants will be followed up until the end of the operation, an expected average of 60 minutes

  • Blood pressure

    Participants will be followed up until the end of hospital stay, an expected average of 7 days

  • Pulse

    Participants will be followed up until the end of hospital stay, an expected average of 7 days

  • Heart rhythm

    Participants will be followed up until the end of hospital stay, an expected average of 7 days

  • +45 more secondary outcomes

Study Arms (2)

Control phase

NO INTERVENTION

Control phase: in this phase, all study patients receive the standard therapy of the respective study center.

Intervention phase

EXPERIMENTAL

In this phase, the intervention with Digi-POD is made available as Clinical Decision Support System. The intervention consists of providing patients, relatives and caregivers with Digi-POD decision support for the prevention of delirium and treatment decisions for delirium in accordance with the recommendations from the guidelines in addition to the standard therapy of the respective study center.

Other: Intervention with clinical decision support system

Interventions

To this phase, patient data is automated and systematically analyzed in order to derive decision support based on current evidence and make it available to Digi-POD users (patients, relatives, nursing staff, doctors, other healthcare professionals).

Intervention phase

Eligibility Criteria

Age70 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Age ≥ 70 years
  • Male and female patients
  • Patients who are insured through statutory health insurance
  • Operation (elective)

You may not qualify if:

  • Insufficient language skills
  • Moribund patients
  • Study relatives
  • Age ≥ 18 years
  • Male and female relatives
  • Insufficient language skills
  • No consent for data entry
  • Substudy of the Charité - University Berlin:
  • \- All inpatients ≥ 18 years of age who have undergone delirium screening with a validated delirium screening instrument

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Institut für Anästhesiologie und Schmerztherapie-Herz- und Diabeteszentrum NRW- Universitätsklinik der Ruhr-Universität Bochum

Bad Oeynhausen, Bochum, 32545, Germany

Location

Department of Anaesthesiolgy and Intensive Care Medicine CCM/CVK, Charite- University Berlin

Berlin, 13355, Germany

Location

CARITAS Klinik Maria Heimsuchung

Berlin, Germany

Location

Klinikum im Friedrichshain - Vivantes - Netzwerk für Gesundheit GmbH

Berlin, Germany

Location

MeSH Terms

Conditions

Emergence Delirium

Interventions

Methods

Condition Hierarchy (Ancestors)

DeliriumConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Investigative Techniques

Study Officials

  • Claudia Spies, MD, Prof.

    Charite University, Berlin, Germany

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
SEQUENTIAL
Model Details: Digi-POD is a multicenter, prospective, longitudinal intervention study in a before-and-after design with quantitative process analysis
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of the Department of Anesthesiology and Intensive Care Medicine (CCM/CVK)

Study Record Dates

First Submitted

May 23, 2024

First Posted

June 6, 2024

Study Start

June 3, 2024

Primary Completion

January 15, 2026

Study Completion (Estimated)

July 31, 2027

Last Updated

May 4, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations